BioSig Technologies Past Earnings Performance
Past criteria checks 0/6
BioSig Technologies has been growing earnings at an average annual rate of 14%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 10.7% per year.
Key information
14.0%
Earnings growth rate
37.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.7% |
| Return on equity | n/a |
| Net Margin | -39,605.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08BioSig signs purchase deal with Kansas City's Overland Park Regional hospital
Jul 07BioSig: PURE EP Economics Trade Exhausted
Jun 14Revenue & Expenses Breakdown
How BioSig Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 0 | -15 | 15 | 2 |
| 30 Jun 24 | 0 | -18 | 16 | 3 |
| 31 Mar 24 | 0 | -25 | 20 | 4 |
| 31 Dec 23 | 0 | -29 | 23 | 5 |
| 30 Sep 23 | 0 | -30 | 24 | 5 |
| 30 Jun 23 | 0 | -32 | 26 | 6 |
| 31 Mar 23 | 0 | -27 | 21 | 5 |
| 31 Dec 22 | 0 | -27 | 21 | 6 |
| 30 Sep 22 | 0 | -29 | 23 | 6 |
| 30 Jun 22 | 0 | -30 | 25 | 6 |
| 31 Mar 22 | 0 | -32 | 27 | 6 |
| 31 Dec 21 | 0 | -32 | 28 | 6 |
| 30 Sep 21 | 0 | -34 | 29 | 7 |
| 30 Jun 21 | 0 | -38 | 30 | 10 |
| 31 Mar 21 | 0 | -49 | 40 | 14 |
| 31 Dec 20 | 0 | -52 | 41 | 18 |
| 30 Sep 20 | 0 | -57 | 43 | 20 |
| 30 Jun 20 | 0 | -51 | 39 | 17 |
| 31 Mar 20 | 0 | -40 | 28 | 13 |
| 31 Dec 19 | 0 | -34 | 25 | 10 |
| 30 Sep 19 | 0 | -25 | 19 | 6 |
| 30 Jun 19 | 0 | -23 | 17 | 5 |
| 31 Mar 19 | 0 | -21 | 15 | 5 |
| 31 Dec 18 | 0 | -18 | 13 | 4 |
| 30 Sep 18 | 0 | -17 | 13 | 4 |
| 30 Jun 18 | 0 | -15 | 11 | 4 |
| 31 Mar 18 | 0 | -12 | 8 | 4 |
| 31 Dec 17 | 0 | -13 | 8 | 5 |
| 30 Sep 17 | 0 | -10 | 5 | 4 |
| 30 Jun 17 | 0 | -9 | 5 | 4 |
| 31 Mar 17 | 0 | -12 | 8 | 4 |
| 31 Dec 16 | 0 | -12 | 8 | 3 |
| 30 Sep 16 | 0 | -12 | 9 | 3 |
| 30 Jun 16 | 0 | -11 | 10 | 2 |
| 31 Mar 16 | 0 | -9 | 10 | 2 |
| 31 Dec 15 | 0 | -10 | 11 | 2 |
| 30 Sep 15 | 0 | -10 | 11 | 1 |
| 30 Jun 15 | 0 | -15 | 13 | 1 |
| 31 Mar 15 | 0 | -11 | 9 | 1 |
| 31 Dec 14 | 0 | -9 | 7 | 1 |
| 30 Sep 14 | 0 | -8 | 6 | 1 |
| 30 Jun 14 | 0 | -6 | 2 | 1 |
| 31 Mar 14 | 0 | -8 | 3 | 1 |
Quality Earnings: BSGM is currently unprofitable.
Growing Profit Margin: BSGM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BSGM is unprofitable, but has reduced losses over the past 5 years at a rate of 14% per year.
Accelerating Growth: Unable to compare BSGM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BSGM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: BSGM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.